Alumis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alumis and other ETFs, options, and stocks.

About ALMS

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies.

CEO

Martin Babler

CEOMartin Babler

Employees

168

Employees168

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2021

Founded2021

Employees

168

Employees168

ALMS Key Statistics

Market cap

295.12M

Market cap295.12M

Price-Earnings ratio

-0.45

Price-Earnings ratio-0.45

Dividend yield

—

Dividend yield—

Average volume

842.70K

Average volume842.70K

High today

$3.15

High today$3.15

Low today

$2.81

Low today$2.81

Open price

$3.01

Open price$3.01

Volume

1.60M

Volume1.60M

52 Week high

$16.00

52 Week high$16.00

52 Week low

$2.81

52 Week low$2.81

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ALMS. This list is generated using Robinhood data, and it’s not a recommendation.